Aarti Drugs Limited (BOM:524348)
India
· Delayed Price · Currency is INR 380.50
-0.85 (-0.22%)
At close: Apr 28, 2026
Aarti Drugs Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 34,728 | 31,240 | 39,886 | 31,280 | 39,725 | 64,755 | Upgrade
|
| Market Cap Growth | 13.49% | -21.68% | 27.51% | -21.26% | -38.65% | 449.47% | Upgrade
|
| Enterprise Value | 40,221 | 36,849 | 45,531 | 36,863 | 44,228 | 67,914 | Upgrade
|
| Last Close Price | 380.50 | 337.99 | 430.52 | 334.56 | 423.81 | 685.08 | Upgrade
|
| PE Ratio | 17.15 | 18.58 | 23.27 | 18.81 | 19.38 | 23.09 | Upgrade
|
| Forward PE | 17.02 | 16.62 | 17.30 | 14.25 | 13.79 | 18.31 | Upgrade
|
| PS Ratio | 1.38 | 1.31 | 1.58 | 1.15 | 1.60 | 3.01 | Upgrade
|
| PB Ratio | 2.36 | 2.28 | 3.11 | 2.62 | 3.83 | 7.09 | Upgrade
|
| P/TBV Ratio | 2.38 | 2.39 | 3.20 | 2.68 | 3.83 | 7.09 | Upgrade
|
| P/FCF Ratio | - | 46.33 | 30.08 | - | - | 97.06 | Upgrade
|
| P/OCF Ratio | - | 12.77 | 11.11 | 23.46 | 56.42 | 41.79 | Upgrade
|
| PEG Ratio | 0.74 | 1.44 | 1.44 | 1.44 | 1.53 | 0.39 | Upgrade
|
| EV/Sales Ratio | 1.59 | 1.54 | 1.80 | 1.36 | 1.78 | 3.15 | Upgrade
|
| EV/EBITDA Ratio | 13.40 | 12.96 | 14.50 | 12.17 | 13.19 | 15.67 | Upgrade
|
| EV/EBIT Ratio | 16.56 | 15.93 | 17.18 | 14.44 | 15.34 | 17.50 | Upgrade
|
| EV/FCF Ratio | - | 54.65 | 34.34 | - | - | 101.79 | Upgrade
|
| Debt / Equity Ratio | 0.39 | 0.45 | 0.44 | 0.51 | 0.52 | 0.38 | Upgrade
|
| Debt / EBITDA Ratio | 1.91 | 2.15 | 1.79 | 1.99 | 1.60 | 0.80 | Upgrade
|
| Debt / FCF Ratio | - | 9.12 | 4.26 | - | - | 5.26 | Upgrade
|
| Net Debt / Equity Ratio | 0.37 | 0.43 | 0.42 | 0.49 | 0.49 | 0.36 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.84 | 2.09 | 1.73 | 1.94 | 1.52 | 0.76 | Upgrade
|
| Net Debt / FCF Ratio | - | 8.79 | 4.10 | -18.69 | -6.23 | 4.93 | Upgrade
|
| Asset Turnover | - | 0.95 | 1.04 | 1.17 | 1.25 | 1.29 | Upgrade
|
| Inventory Turnover | - | 3.26 | 3.39 | 3.67 | 3.62 | 3.60 | Upgrade
|
| Quick Ratio | - | 0.95 | 0.92 | 0.94 | 0.84 | 0.97 | Upgrade
|
| Current Ratio | - | 1.60 | 1.66 | 1.57 | 1.48 | 1.78 | Upgrade
|
| Return on Equity (ROE) | - | 12.68% | 13.87% | 14.93% | 21.03% | 35.81% | Upgrade
|
| Return on Assets (ROA) | - | 5.77% | 6.83% | 6.89% | 9.07% | 14.52% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.51% | 9.69% | 10.71% | 11.39% | 15.72% | 26.05% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 13.30% | 16.20% | 17.30% | 22.70% | 33.20% | Upgrade
|
| Earnings Yield | 5.83% | 5.38% | 4.30% | 5.32% | 5.16% | 4.33% | Upgrade
|
| FCF Yield | - | 2.16% | 3.32% | -1.01% | -2.05% | 1.03% | Upgrade
|
| Dividend Yield | 0.52% | 0.30% | 0.23% | 0.30% | 0.24% | 0.36% | Upgrade
|
| Payout Ratio | - | 5.39% | 5.41% | 5.65% | 4.64% | 8.28% | Upgrade
|
| Buyback Yield / Dilution | 0.18% | 0.72% | 0.72% | - | 0.64% | - | Upgrade
|
| Total Shareholder Return | 0.70% | 1.02% | 0.95% | 0.30% | 0.88% | 0.36% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.